However, the absence of MIF can increase the expression of CD4+T and CD8+T in tumor tissue, activate more dendritic cells, promote the occurrence of immunogenic cell death, and produce severe anti-tumor immune response (105), which provides a direction for the treatment of tumors with high expression of MIF. The gene discussed is CD8A; the disease is neoplasm.